Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -48.04M
June 30, 2026 50.80M
March 31, 2026 10.94M
December 31, 2025 11.15M
September 30, 2025 19.08M
June 30, 2025 53.40M
March 31, 2025 27.73M
December 31, 2024 -27.46M
September 30, 2024 8.985M
June 30, 2024 7.304M
March 31, 2024 -47.19M
December 31, 2023 24.27M
September 30, 2023 20.08M
June 30, 2023 -1.096M
March 31, 2023 -4.354M
December 31, 2022 -92.60M
September 30, 2022 44.29M
June 30, 2022 -213.69M
March 31, 2022 0.688M
December 31, 2021 -140.27M
September 30, 2021 -34.78M
June 30, 2021 -155.00M
Date Value
March 31, 2021 -216.49M
December 31, 2020 -318.77M
September 30, 2020 -1.404M
June 30, 2020 -2.405M
March 31, 2020 -3.862M
December 31, 2019 -36.08M
September 30, 2019 6.344M
June 30, 2019 3.211M
March 31, 2019 -2.522M
December 31, 2018 -2.536M
September 30, 2018 4.962M
June 30, 2018 -1.527M
March 31, 2018 0.051M
December 31, 2017 -1.763M
September 30, 2017 -2.568M
June 30, 2017 4.152M
March 31, 2017 -1.87M
December 31, 2016 -39.42M
September 30, 2016 -2.816M
June 30, 2016 -0.386M
March 31, 2016 -0.177M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Quest Diagnostics, Inc. -169.00M
Labcorp Holdings, Inc. -433.70M
OPKO Health, Inc. 11.30M
Psychemedics Corp. --
NeoGenomics, Inc. -11.85M